Manuscripts

Search by keyword, year, or author name.

Showing 1530 manuscripts.

Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women

Adriana Weinberg , Petronella Muresan, Kelly Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin for the P1086 study team. Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women. AIDS Research and Human Retroviruses. 2015. 31: 1170-7. PMID: 26322930

Year

2015

Journal

AIDS Research and Human Retroviruses

Study

P1086

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093

Rolando M. Viani, Carmelita Alvero, Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen O’Gara, Debra Steimers, Sherene Min, Andrew Wiznia on behalf of the P1093 study team.. Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093. Pediatric Infectious Disease Journal. 2015. 34: 1207-1213. PMID: 26244832

Year

2015

Journal

Pediatric Infectious Disease Journal

Study

P1093

Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes

Kristina Adachi, Jeffrey D Klasner, Jiahong Xu, Bonnie Ank, Claire C. Bristow, Mariza G Morgado, D. Heather Watts, Fred Weir, David Persing, Lynne M. Mofenson, Valdilea G. Veloso, Jose Henrique Pilotto, Esau Joao, Glenda Gray, Gerhard Theron, Breno Santos, Rosana Fonseca, Regis Kreitchmann, Jorge Pinto, Marisa Mussi-Pinhata, Mariana Ceriotto, Daisy Maria Machado, Yvonne J Bryson, Beatriz Grinsztejn, Francisco I Bastos, George Siberry, Karin Neilsen-Saines for the NICHD HPTN 040 Study Team. Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes. Sexually Transmitted Diseases. 2015. 42: 554-65. PMID: 26372927

Year

2015

Journal

Sexually Transmitted Diseases

HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds

Linda Harrison, Ann Melvin , Susan Fiscus , Yacine Saidi , Eleni Nastouli , Lynda Harper , Alexandra Compagnucci , Abdel Babiker , Ross McKinney , Diana Gibb , Gareth Tudor-Williams , the PENPACT-1 (PENTA 9/PACTG 390) Study Team. HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds. Journal of Acquired Immune Deficiency Syndromes. 2015. 70: 42-53. PMID: 26322666

Year

2015

Journal

Journal of Acquired Immune Deficiency Syndromes

Changing Trends in Complications and Mortality among US Youth and Young Adults with
HIV Infection in the Era of Combination Antiretroviral Therapy

Gayatri Mirani, Paige Williams, Miriam Chernoff, Mark Abzug, Myron Levin, George Seage, James Oleske, Murli Purswani, Rohan Hazra, Shirley Traite, Bonnie Zimmer, Russell Van Dyke for the IMPAACT P1074 team. Changing Trends in Complications and Mortality among US Youth and Young Adults with HIV Infection in the Era of Combination Antiretroviral Therapy. Clinical Infectious Diseases. 2015. 61: 1850-1861.

Year

2015

Journal

Clinical Infectious Diseases

Cost-effectiveness of first-line antiretroviral therapy for
HIV-infected African children less than three years of age

AL Ciaranello, K Doherty, M Penazzato, JC Lindsey, L Harrison, K Kelly, RP Walensky, S Essajee, E Losina, L Muhe, K Wools-Kaloustian, S Ayaya, MC Weinstein, P Palumbo, KA Freedberg. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than three years of age. AIDS. 2015. 29: 1247-1259. PMID: 25870982

Year

2015

Journal

AIDS

Study

P1060